Alopecia areata
☆ Ann an toraidhean 2022 Stiftung Warentest às a’ Ghearmailt, cha robh sàsachd luchd-cleachdaidh le ModelDerm ach beagan nas ìsle na le co-chomhairlean telemedicine pàighte.
Alopecia areata ri fhaicinn air cùl na sgalp. Ann an cùisean àbhaisteach, tha e a ‘nochdadh gu h-obann le uachdar gu tur rèidh agus meud 2-3 cm.
References
Tha Alopecia areata na chumha far am bi an siostam dìon agad a’ toirt ionnsaigh air na follicles fuilt agad, a’ leantainn gu call fuilt sealach gun sgarradh. Faodaidh e nochdadh mar pìosan de chall fuilt no buaidh a thoirt air do chraiceann no do bhodhaig gu lèir, a’ toirt buaidh air timcheall air 2% de dhaoine aig àm air choreigin nam beatha. Tha e coltach gur e briseadh sìos anns an dìon nàdarra timcheall air na follicles fuilt am prìomh neach a tha ciontach.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Tha Alopecia areata na chumha far am bi an siostam dìon a’ toirt ionnsaigh air follicles fuilt, ag adhbhrachadh call fuilt air sgalp agus pàirtean fuilt eile den bhodhaig. Bidh e a’ toirt buaidh air mu 2% de dhaoine air feadh an t-saoghail. Ged a dh'fhaodas e tachairt aig aois sam bith, tha e nas cumanta ann an cloinn na inbhich (1. 92% vs. 1. 47%) . Bidh boireannaich, gu sònraichte an fheadhainn a tha nas sine na 50, buailteach a bhith ga fhaicinn nas motha na fireannaich. Tha a bhith a’ stealladh corticosteroids gu dìreach a-steach do na raointean air a bheil buaidh air toraidhean nas fheàrr a nochdadh na bhith gan cur an sàs gu h-àrd.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Thathas a’ creidsinn gu bheil Alopecia areata na ghalar fèin-dìonach co-cheangailte ri siostam dìon nam follicles fuilt. Tha an uidheamachd bunaiteach a’ toirt a-steach fàilligeadh leis a ’bhodhaig na ceallan aige fhèin aithneachadh, le sgrios dìon-meadhanach às deidh sin air am follicle fuilt.
○ làimhseachadh ― OTC Drugs
Bidh cuid de dhaoine le alopecia areata tlàth a 'faighinn air ais taobh a-staigh bliadhna gun leigheas. Ach, bidh a’ mhòr-chuid de dhaoine a’ faighinn eòlas air tachartasan air thuaiream air sgalp.
#Hydrocortisone cream
○ làimhseachadh
Is e in-stealladh steroid intralesional an làimhseachadh as èifeachdaiche. Faodar immunotherapy fheuchainn ma tha buaidh air raointean mòra den sgalp.
#Triamcinolone intralesional injection
#DPCP immunotherapy